Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Enliven Therapeutics, Inc.

Pharmaceutical Preparations · Burlingame, CA, United States

  1. PrincipalsAnish PatelCHIEF OPERATING OFFICERBenjamin HohlCHIEF FINANCIAL OFFICERHelen Louise CollinsCHIEF MEDICAL OFFICERand 10 more
  2. CompanyEnliven Therapeutics, Inc.Burlingame, CA, United States
  3. Phone line+1 (650) 547-5814General business
Request a quote

Enliven Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker ELVN) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 13

Chief executive

Richard A. FairPRESIDENT AND CEO
Samuel KintzPRESIDENT AND CEO

Chair & board

J. Scott GarlandDirector (Board)
Jake BauerDirector (Board)
Lori Anne KunkelDirector (Board)
Mika K DerynckDirector (Board)

Finance

Benjamin HohlCHIEF FINANCIAL OFFICER

Operations

Anish PatelCHIEF OPERATING OFFICER
Everyone else on file (2)
Helen Louise CollinsCHIEF MEDICAL OFFICER
Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Helen Louise Collins — CHIEF MEDICAL OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Anish Patel — CHIEF OPERATING OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Joseph P Lyssikatos — CHIEF SCIENTIFIC OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Benjamin Hohl — CHIEF FINANCIAL OFFICER

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers